4-cymene has been researched along with Cancer-Associated Pain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Almeida, JRGS; Baj, T; Batista, MVA; Coutinho, HDM; de Oliveira, MA; Duarte, MC; Guimarães, AG; Kowalska, G; Kowalski, R; Pina, LTS; Quintans, JSS; Quintans-Júnior, LJ; Santos, LABO; Santos, WBR; Serafini, MR; Trindade, GGG | 1 |
Alves, RS; Bezerra, DP; de Brito, RG; de Menezes-Filho, JER; de Vasconcelos, CML; Guimarães, AG; Lucca Júnior, W; Melo, MAO; Prado, LDS; Quintans-Júnior, LJ; Rabelo, TK; Santos, WBR; Scotti, L; Scotti, MT; Silva, VKDS; Souza, DS | 1 |
2 other study(ies) available for 4-cymene and Cancer-Associated Pain
Article | Year |
---|---|
Antinociceptive Effect of a p-Cymene/β-Cyclodextrin Inclusion Complex in a Murine Cancer Pain Model: Characterization Aided through a Docking Study.
Topics: Analgesics; Animals; beta-Cyclodextrins; Cancer Pain; Cyclodextrins; Humans; Mice; Molecular Docking Simulation; Neoplasms; Pain; Solubility | 2023 |
p-Cymene attenuates cancer pain via inhibitory pathways and modulation of calcium currents.
Topics: Analgesics, Non-Narcotic; Animals; Calcium; Cancer Pain; Cymenes; Hyperalgesia; Male; Mice; Neurons; Nociceptive Pain; Proto-Oncogene Proteins c-fos; Random Allocation; Sarcoma 180; Spinal Cord | 2019 |